Topic
Bacillus Calmette-Guérin (BCG)
11 Podcasts • 3 Courses on BackTable
Episode # 63 • 04 Jun 2026
Launching Co-Managed APP/MD Clinics for Bladder Cancer
Are traditional bladder cancer care models falling behind as new therapies flood the field and reshape the landscape? In this episode of BackTable Urology, Dr. Bogdana Schmidt talks with Dr. Amy Luckenbaugh and DNP/APP Meredith Donahue about building a co-managed intravesical therapy clinic that rethinks care for patients with non–muscle invasive bladder cancer (NMIBC). With innovative agents increasing patient volume and complexity, the team discusses adapting care models to new realities.
This podcast is supported by an educational grant from Johnson & Johnson.
More on Bacillus Calmette-Guérin (BCG)
Loading recent podcasts…
Tumor Board # 63
Jun 4, 2026
with Dr. Amy Luckenbaugh, Meredith Donahue NP, Dr. Bogdana Schmidt
Are traditional bladder cancer care models falling behind as new therapies flood the field and reshape the landscape?...
270+ listens
Urology # 271
Nov 7, 2025
with Dr. Katie Murray, Dr. Sarah Psutka, Dr. Vignesh Packiam
As new genetic and AI-powered tools emerge for bladder cancer screening, are we getting closer to reducing the need for...
1,300+ listens
Urology # 266
Oct 17, 2025
with Dr. Sima Porten, Dr. Patrick Hensley, Dr. Vignesh Packiam
When a patient is diagnosed with non-muscle invasive bladder cancer (NMIBC), how do you tailor the conversation and...
1,100+ listens
Tumor Board # 28
Oct 7, 2025
with Dr. Katie Murray, Dr. Sarah Psutka, Dr. Vignesh Packiam
As new genetic and AI-powered tools emerge for bladder cancer screening, are we getting closer to reducing the need for...
230+ listens
Urology # 273
Nov 14, 2025
with Meredith Donahue NP, Brynn Moore RN, Dr. Ruchika Talwar
With the right protocols (and the right team!), urology clinics can proactively manage the side effects of intravesical...
1,000+ listens
Urology # 267
Oct 21, 2025
with Dr. Mark Tyson, Dr. Suzanne Merrill, Dr. Bogdana Schmidt
New FDA-approved therapies for BCG-refractory non-muscle invasive bladder cancer (NMIBC)–where do they fit in the...
1,400+ listens
Tumor Board # 29
Oct 7, 2025
with Meredith Donahue NP, Brynn Moore RN, Dr. Ruchika Talwar
With the right protocols (and the right team!), urology clinics can proactively manage the side effects of intravesical...
740+ listens
Tumor Board # 26
Oct 7, 2025
with Dr. Mark Tyson, Dr. Suzanne Merrill, Dr. Bogdana Schmidt
New FDA-approved therapies for BCG-refractory non-muscle invasive bladder cancer (NMIBC)–where do they fit in the...
140+ listens
Urology Course
3 hours, 28 lessons
The Materials available on BackTable are provided for informational and educational purposes only and are not a substitute for the independent professional judgment of a qualified healthcare professional in diagnosing or treating patients. Any opinions, statements, or views expressed are those of the individual contributors and do not necessarily reflect those of the publisher, platform, or any affiliated organization.